OPKO Health, Inc.
OPK · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $3 |
| Revenue | $1 | $1 | $1 | $2 |
| % Growth | -17.4% | -14% | -43.4% | – |
| Gross Profit | $0 | $0 | $0 | $1 |
| % Margin | 43.6% | 36.8% | 28.7% | 32.8% |
| EBITDA | $0 | -$0 | -$0 | $0 |
| % Margin | 19% | -7.6% | -27% | 4.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -7.5% | -21.9% | -32.7% | -1.7% |
| EPS Diluted | -0.077 | -0.25 | -0.46 | -0.046 |
| % Growth | 69.3% | 45.7% | -911% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |